HEATHER DOYLE: Open Payments
NPI 1366726275 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,316 in 67 payments from 20 companies in 2025. Trend: 2023 $378 · 2024 $847 · 2025 $1,316
Food & beverage: $1,316
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $256 |
| PFIZER INC. | 12 | $243 |
| ABBVIE INC. | 12 | $139 |
| Neurocrine BioSciences, Inc. | 3 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $74 |
| Axsome Therapeutics, Inc. | 4 | $66 |
| Biogen, Inc. | 3 | $59 |
| Lundbeck LLC | 3 | $50 |
| Neurelis, Inc. | 2 | $44 |
| ARGENX US, INC. | 2 | $42 |
Products named: AUSTEDO XR, ZAVZPRET, QULIPTA, INGREZZA, NURTEC ODT, KESIMPTA, Symbravo, VYEPTI.
Industry payments across TX — which companies pay providers there.
